We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
-$1.12B
Cap. Flow %
-1.77%
Top 10 Hldgs %
32.11%
Holding
999
New
156
Increased
303
Reduced
370
Closed
127

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.35B
2
INSM icon
Insmed
INSM
+$197M
3
HUBB icon
Hubbell
HUBB
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
SLNO
Soleno Therapeutics
SLNO
+$161M

Sector Composition

Rank Sector Weight
1 Technology 30.31%
2 Healthcare 13.97%
3 Financials 11.89%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PARA
951
DELISTED
Paramount Global Class B
PARA
-551,185
Closed -$7.11M
PAY icon
952
Paymentus
PAY
$5.05B
-14,588
Closed -$478K
PNFP icon
953
Pinnacle Financial Partners Inc
PNFP
$16.1B
-99,000
Closed -$10.9M
PNR icon
954
Pentair
PNR
$11.2B
-483,702
Closed -$49.7M
POR icon
955
Portland General Electric
POR
$5.71B
-300,000
Closed -$12.2M
PRA
956
DELISTED
ProAssurance
PRA
-492,566
Closed -$11.2M
PRCT icon
957
Procept Biorobotics
PRCT
$1.14B
-100,000
Closed -$5.76M
RF icon
958
Regions Financial
RF
$26.8B
-198,300
Closed -$4.66M
RH icon
959
RH
RH
$3.56B
-50,000
Closed -$9.45M
RRX icon
960
Regal Rexnord
RRX
$11.9B
-37,529
Closed -$5.44M
SANA icon
961
Sana Biotechnology
SANA
$949M
-702,000
Closed -$1.92M
SGML icon
962
Sigma Lithium
SGML
$1.21B
-900,000
Closed -$4.05M
SHOP icon
963
Shopify
SHOP
$191B
-24,000
Closed -$2.77M
SILJ icon
964
Amplify Junior Silver Miners ETF
SILJ
$3.63B
-250,000
Closed -$3.7M
SKWD icon
965
Skyward Specialty Insurance
SKWD
$2.66B
-20,000
Closed -$1.16M
SKX
966
DELISTED
Skechers
SKX
-848,872
Closed -$53.6M
SPRY icon
967
ARS Pharmaceuticals
SPRY
$551M
-1,728,000
Closed -$30.2M
SSTK icon
968
Shutterstock
SSTK
$217M
-100,000
Closed -$1.9M
STR
969
DELISTED
Sitio Royalties
STR
-6,783,254
Closed -$125M
SUI icon
970
Sun Communities
SUI
$14.7B
-80,000
Closed -$10.1M
SYRE icon
971
Spyre Therapeutics
SYRE
$9.12B
-610,200
Closed -$9.13M
TAK icon
972
Takeda Pharmaceutical
TAK
$54.4B
-2,533,725
Closed -$39.2M
TARA icon
973
Protara Therapeutics
TARA
$230M
-400,000
Closed -$1.21M
TARS icon
974
Tarsus Pharmaceuticals
TARS
$2.85B
-543,000
Closed -$22M
TEVA icon
975
Teva Pharmaceuticals
TEVA
$40.6B
-534,000
Closed -$8.95M

Similar funds

Adage Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adage Capital Partners held 999 positions worth $63.1B, up 6.4% from $59.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q3 2025 filing shows 156 new, 303 increased, 370 reduced and 127 closed positions. Its largest new stake was Chevron: 3,284,841 shares worth $510M. The largest sale was Hess, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2025 buy was Chevron: 3,284,841 shares worth $510M.
  • Adage Capital Partners added most to Royalty Pharma in Q3 2025, an estimated $216M increase.
  • Adage Capital Partners's biggest Q3 2025 reduction was Insmed, cutting an estimated $197M.
  • Adage Capital Partners fully exited Hess in Q3 2025, selling an estimated $1.35B.
  • Adage Capital Partners's ten largest holdings make up 32% of its $63.1B portfolio in Q3 2025.
  • Adage Capital Partners opened 156 new positions and closed 127 in Q3 2025.
  • Adage Capital Partners's portfolio value rose 6.4% quarter-over-quarter to $63.1B.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.